Overview

The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes

Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This study aims to explore the effectiveness and safety of the in-hospital-out-of-hospital synergistic short-term insulin intensive therapy model based on patch insulin pump and continuous glucose monitoring technology through a randomized controlled study, and evaluate the possibility of blood glucose parameters derived from continuous glucose technology in predicting long-term blood glucose remission, so as to provide important reference data for the precision, intelligence, and integrated improvement of short-term insulin intensive therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Dapagliflozin
Insulin
Insulin Aspart
Insulin Glargine
Insulin, Globin Zinc
Metformin